Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Bone and Calcium Disorders
Is the FRAX score reliable in assessing fracture risk for patients with history of prior bisphosphonate use?
Related Questions
Is there a maximum duration for raloxifene use?
Do you recommend the use of albumin-adjusted calcium measurement formulas to accurately assess calcium levels?
When interpreting bone density reports, are T-scores adjusted for different age brackets?
Is there any data on denosumab use beyond 10 years from the FREEDOM Extension trial, and what do we know about the risk of atypical femoral fracture and osteonecrosis of the jaw after 10 years?
Which method provides a more accurate assessment of hypercalciuria: 24-hour urinary calcium excretion or the spot urine calcium-to-creatinine ratio?
Would you start romosozumab in an active smoker?
In post-bariatric surgery patients presenting with secondary hyperparathyroidism, what is the optimal approach to assess calcium supplementation adequacy?
Do you routinely prescribe vitamin D to reduce the risk of fall-related fractures in elderly patients regardless of their serum levels?
Do you use bone turnover markers to assess medical adherence in patients treated for osteoporosis?
In a patient with a history of parathyroidectomy (due to primary hyperparathyroidism) with low T- scores and high risk of fractures, is there any contraindication to give teriparatide/Forteo if PTH is in normal range after surgery?
